Carlsmed Inc (CARL)

Currency in USD
12.97
-0.36(-2.70%)
Closed·
13.29+0.32(+2.47%)
·
CARL Scorecard
Full Analysis
Analysts do not anticipate the company will be profitable this year
CARL is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
12.8113.46
52 wk Range
11.8116.20
Key Statistics
Prev. Close
13.33
Open
13.4
Day's Range
12.81-13.46
52 wk Range
11.81-16.2
Volume
151.05K
Average Volume (3m)
223.28K
1-Year Change
-
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CARL Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
18.40
Upside
+41.87%
Members' Sentiments
Bearish
Bullish
ProTips
Liquid assets exceed short term obligations

Carlsmed Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Carlsmed Inc Company Profile

Carlsmed, Inc., a commercial-stage company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.

Carlsmed Inc Earnings Call Summary for Q2/2025

  • Q2 2025 revenue surged 99% YoY to $12.1M; stock rose 1.87% in aftermarket trading, building on 7.92% weekly gain
  • Full-year 2025 revenue guidance set at $45.5M-$47.5M, projecting 67-75% growth; gross margin decreased to 73.4% from 75% in 2024
  • Aprivo technology platform shows 82.6% reduction in reoperation rates; cervical platform commercial launch planned for 2026
  • $33.5M cash position, bolstered by $100.5M from July IPO; GAAP net loss of $6.8M reported for the quarter
  • Company focuses on AI integration for surgical planning; aims to expand market share in $13B lumbar spine fusion market
Last Updated: 28/08/2025, 22:24
Read Full Transcript

Compare CARL to Peers and Sector

Metrics to compare
CARL
Peers
Sector
Relationship
P/E Ratio
−13.2x−4.1x−0.6x
PEG Ratio
-−0.180.00
Price/Book
−4.2x3.7x2.6x
Price / LTM Sales
9.0x3.1x3.4x
Upside (Analyst Target)
38.8%28.7%35.5%
Fair Value Upside
Unlock3.5%3.7%Unlock

Analyst Ratings

5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 18.40
(+41.87% Upside)

Earnings

Latest Release
Aug 28, 2025
EPS / Forecast
-1.47 / --
Revenue / Forecast
12.08M / --
EPS Revisions
Last 90 days

CARL Income Statement

People Also Watch

64.81
BLSH
-4.56%
27.37
FLY
+2.13%
31.20
WYFI
-7.36%
200.74
ALAB
-4.23%
31.78
CAI
+6.97%

FAQ

What Stock Exchange Does Carlsmed Trade On?

Carlsmed is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Carlsmed?

The stock symbol for Carlsmed is "CARL."

What Is the Carlsmed Market Cap?

As of today, Carlsmed market cap is 344.76M.

What Is Carlsmed's Earnings Per Share (TTM)?

The Carlsmed EPS (TTM) is -6.13.

When Is the Next Carlsmed Earnings Date?

Carlsmed will release its next earnings report on 02 Dec 2025.

From a Technical Analysis Perspective, Is CARL a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Carlsmed Stock Split?

Carlsmed has split 0 times.

How Many Employees Does Carlsmed Have?

Carlsmed has 89 employees.

What is the current trading status of Carlsmed (CARL)?

As of 05 Oct 2025, Carlsmed (CARL) is trading at a price of 12.97, with a previous close of 13.33. The stock has fluctuated within a day range of 12.81 to 13.46, while its 52-week range spans from 11.81 to 16.20.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.